Floatz logo

FENTANYL

T-cell Type Acute Leukemia-Precursor

SanofiSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the T-cell Type Acute Leukemia-Precursor cohort.

Asset / SponsorPhaseRating
RANITIDINE
Sanofi
Phase 2CCC
Benadryl
Sanofi
Phase 2CCC
Ketorolac Tromethamine
Sanofi
Phase 2CCC
Isatuximab
Sanofi
Phase 2CCC
HYDROMORPHON
Sanofi
Phase 2CCC
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Sanofi
Phase 2CCC

Same molecule, other indications

FENTANYL is also rated in:

Low Back PainDormant
BBB
Indicative ·
75 / 100
View asset →
PainDormant
BBB
Indicative ·
74 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →